Cytosorbents Pre-Tax Profit Margin 2012-2025 | CTSO
Cytosorbents pre-tax profit margin from 2012 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Cytosorbents Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $0.04B | $-0.01B | -32.43% |
| 2025-06-30 | $0.04B | $-0.01B | -29.73% |
| 2025-03-31 | $0.04B | $-0.02B | -47.22% |
| 2024-12-31 | $0.04B | $-0.02B | -61.11% |
| 2024-09-30 | $0.03B | $-0.02B | -66.67% |
| 2024-06-30 | $0.03B | $-0.03B | -86.67% |
| 2024-03-31 | $0.03B | $-0.03B | -93.33% |
| 2023-12-31 | $0.03B | $-0.03B | -96.67% |
| 2023-09-30 | $0.04B | $-0.02B | -66.67% |
| 2023-06-30 | $0.04B | $-0.03B | -77.14% |
| 2023-03-31 | $0.03B | $-0.03B | -94.12% |
| 2022-12-31 | $0.03B | $-0.03B | -100.00% |
| 2022-09-30 | $0.04B | $-0.04B | -116.67% |
| 2022-06-30 | $0.04B | $-0.04B | -94.74% |
| 2022-03-31 | $0.04B | $-0.03B | -71.43% |
| 2021-12-31 | $0.04B | $-0.03B | -56.82% |
| 2021-09-30 | $0.05B | $-0.02B | -37.78% |
| 2021-06-30 | $0.05B | $-0.01B | -26.09% |
| 2021-03-31 | $0.04B | $-0.01B | -22.73% |
| 2020-12-31 | $0.04B | $-0.01B | -21.43% |
| 2020-09-30 | $0.04B | $-0.01B | -32.43% |
| 2020-06-30 | $0.03B | $-0.02B | -56.25% |
| 2020-03-31 | $0.03B | $-0.02B | -67.86% |
| 2019-12-31 | $0.02B | $-0.02B | -87.50% |
| 2019-09-30 | $0.02B | $-0.02B | -95.65% |
| 2019-06-30 | $0.02B | $-0.02B | -78.26% |
| 2019-03-31 | $0.02B | $-0.02B | -86.96% |
| 2018-12-31 | $0.02B | $-0.02B | -78.26% |
| 2018-09-30 | $0.02B | $-0.02B | -72.73% |
| 2018-06-30 | $0.02B | $-0.02B | -75.00% |
| 2018-03-31 | $0.02B | $-0.01B | -61.11% |
| 2017-12-31 | $0.02B | $-0.01B | -62.50% |
| 2017-09-30 | $0.01B | $-0.01B | -78.57% |
| 2017-06-30 | $0.01B | $-0.01B | -91.67% |
| 2017-03-31 | $0.01B | $-0.01B | -120.00% |
| 2016-12-31 | $0.01B | $-0.01B | -133.33% |
| 2016-09-30 | $0.01B | $-0.01B | -137.50% |
| 2016-06-30 | $0.01B | $-0.01B | -171.43% |
| 2016-03-31 | $0.01B | $-0.01B | -133.33% |
| 2015-12-31 | $0.01B | $-0.01B | -220.00% |
| 2015-09-30 | $0.00B | $-0.01B | -300.00% |
| 2015-06-30 | $0.00B | $-0.01B | -250.00% |
| 2015-03-31 | $0.00B | $-0.01B | -325.00% |
| 2014-12-31 | $0.00B | $-0.01B | -225.00% |
| 2014-09-30 | $0.00B | $-0.01B | -125.00% |
| 2014-06-30 | $0.00B | $-0.01B | -125.00% |
| 2014-03-31 | $0.00B | $0.00B | -133.33% |
| 2013-12-31 | $0.00B | $-0.01B | -250.00% |
| 2013-09-30 | $0.00B | $-0.01B | -250.00% |
| 2013-06-30 | $0.00B | $-0.01B | -250.00% |
| 2013-03-31 | $0.00B | $-0.01B | -250.00% |
| 2012-12-31 | $0.00B | $0.00B | -200.00% |
| 2012-09-30 | $0.00B | $0.00B | -400.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.043B | $0.036B |
| CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $190.250B | 21.25 |
| EssilorLuxottica (ESLOY) | France | $141.053B | 0.00 |
| Stryker (SYK) | United States | $140.785B | 27.01 |
| Boston Scientific (BSX) | United States | $136.192B | 31.14 |
| Medtronic (MDT) | Ireland | $131.676B | 18.24 |
| Medline (MDLN) | United States | $59.144B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.791B | 0.00 |
| Agilent Technologies (A) | United States | $38.383B | 24.26 |
| ResMed (RMD) | United States | $37.110B | 24.78 |
| GE HealthCare Technologies (GEHC) | United States | $36.492B | 17.45 |
| Koninklijke Philips (PHG) | Netherlands | $27.828B | 18.18 |
| Terumo (TRUMY) | Japan | $19.515B | 22.05 |
| Insulet (PODD) | United States | $18.052B | 56.03 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.087B | 10.66 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.556B | 0.00 |
| Baxter (BAX) | United States | $10.214B | 8.24 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.023B | 28.85 |
| Demant (WILYY) | Denmark | $7.483B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.410B | 13.43 |
| Envista Holdings (NVST) | United States | $3.825B | 21.94 |
| BillionToOne (BLLN) | United States | $3.824B | 0.00 |
| ICU Medical (ICUI) | United States | $3.739B | 23.74 |
| Prestige Consumer Healthcare (PBH) | United States | $3.147B | 14.35 |
| Haemonetics (HAE) | United States | $3.079B | 13.70 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.007B | 0.00 |
| Neogen (NEOG) | United States | $2.230B | 48.81 |
| Perrigo (PRGO) | Ireland | $1.971B | 4.94 |
| LeMaitre Vascular (LMAT) | United States | $1.960B | 39.45 |
| QuidelOrtho (QDEL) | United States | $1.878B | 12.07 |
| AtriCure (ATRC) | United States | $1.831B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.699B | 16.97 |
| Curaleaf Holdings (CURLF) | Canada | $1.472B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.459B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.394B | 61.09 |
| AdaptHealth (AHCO) | United States | $1.368B | 19.80 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.159B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.075B | 319.00 |
| Capricor Therapeutics (CAPR) | United States | $1.056B | 0.00 |
| InMode (INMD) | Israel | $1.051B | 11.87 |
| Tilray Brands (TLRY) | Canada | $0.867B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.862B | 0.00 |
| Omeros (OMER) | United States | $0.831B | 0.00 |
| Valneva SE (VALN) | France | $0.788B | 0.00 |
| CeriBell (CBLL) | United States | $0.750B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.594B | 16.09 |
| Brainsway (BWAY) | Israel | $0.455B | 77.50 |
| Verano Holdings (VRNO) | United States | $0.450B | 0.00 |
| Cerus (CERS) | United States | $0.446B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.402B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.372B | 0.00 |
| Evolus (EOLS) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.304B | 24.24 |
| Quanterix (QTRX) | United States | $0.304B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.255B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.228B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.222B | 130.67 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Organigram Global (OGI) | Canada | $0.204B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.199B | 0.00 |
| High Tide (HITI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.198B | 17.75 |
| Sanara MedTech (SMTI) | United States | $0.196B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.188B | 0.00 |
| Accendra Health (ACH) | United States | $0.176B | 1.76 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.135B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.77 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.109B | 0.00 |
| Biote (BTMD) | United States | $0.104B | 4.54 |
| Exagen (XGN) | United States | $0.087B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.50 |
| Sharps Technology (STSS) | United States | $0.049B | 0.00 |
| Nephros (NEPH) | United States | $0.049B | 35.15 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.035B | 17.86 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Flora Growth (ZSTK) | United States | $0.008B | 0.00 |
| INLIF (INLF) | China | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |